144 related articles for article (PubMed ID: 21372465)
21. Goodpasture's syndrome associated with thrombotic thrombocytopenic purpura secondary to an ADAMTS-13 deficit.
Vega-Cabrera C; Del Peso G; Bajo A; Picazo ML; Rivas-Becerra B; Benitez AL; Ara JM; Olea T; Selgas R
Int Urol Nephrol; 2013 Dec; 45(6):1785-9. PubMed ID: 23111709
[TBL] [Abstract][Full Text] [Related]
22. Thrombotic thrombocytopenic purpura in IgG4-related disease with severe deficiency of ADAMTS-13 activity and IgG4 autoantibody against ADAMTS-13.
Saeki T; Ito T; Youkou A; Ishiguro H; Sato N; Yamazaki H; Koike T; Kourakata H; Ferrari S; Scheiflinger F; Narita I
Arthritis Care Res (Hoboken); 2011 Aug; 63(8):1209-12. PubMed ID: 21523922
[No Abstract] [Full Text] [Related]
23. Acquired thrombotic thrombocytopenia purpura associated with severe ADAMTS13 deficiency in a 3-year-old boy: a case report and review of the literature.
Alias H; Yong WL; Muttlib FAA; Koo HW; Loh CK; Lau SCD; Alauddin H; Azma RZ
J Med Case Rep; 2018 Sep; 12(1):276. PubMed ID: 30223886
[TBL] [Abstract][Full Text] [Related]
24. Minor stroke as singular manifestation of hereditary thrombotic thrombocytopenic purpura in a young man.
Lindblom A; Thorsen S; Hillarp A; Björk P
Int Angiol; 2009 Aug; 28(4):336-9. PubMed ID: 19648879
[TBL] [Abstract][Full Text] [Related]
25. Tacrolimus (FK506) associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in lung transplant salvage with a plasmapheresis and cyclosporin.
Boctor FN
Egypt J Immunol; 2006; 13(2):95-9. PubMed ID: 18689275
[TBL] [Abstract][Full Text] [Related]
26. Thrombotic thrombocytopenic purpura.
Koyfman A; Brém E; Chiang VW
Pediatr Emerg Care; 2011 Nov; 27(11):1085-8; quiz 1089-90. PubMed ID: 22068077
[TBL] [Abstract][Full Text] [Related]
27. [Transplantation related ADAMTS13 deficiency in thrombotic thrombocytopenic purpura: a case report and literature review].
Zhang W; Han Y; Su J; Bai X; Jin S; Xu M; Sun A; Ruan C; Wu D
Zhonghua Xue Ye Xue Za Zhi; 2014 Jan; 35(1):69-70. PubMed ID: 24602740
[No Abstract] [Full Text] [Related]
28. ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission.
Peyvandi F; Lavoretano S; Palla R; Feys HB; Vanhoorelbeke K; Battaglioli T; Valsecchi C; Canciani MT; Fabris F; Zver S; Réti M; Mikovic D; Karimi M; Giuffrida G; Laurenti L; Mannucci PM
Haematologica; 2008 Feb; 93(2):232-9. PubMed ID: 18223285
[TBL] [Abstract][Full Text] [Related]
29. Thrombotic thrombocytopenic purpura: a moving target.
Sadler JE
Hematology Am Soc Hematol Educ Program; 2006; ():415-20. PubMed ID: 17124092
[TBL] [Abstract][Full Text] [Related]
30. The course of ADAMTS-13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine.
Böhm M; Betz C; Miesbach W; Krause M; von Auer C; Geiger H; Scharrer I
Br J Haematol; 2005 Jun; 129(5):644-52. PubMed ID: 15916687
[TBL] [Abstract][Full Text] [Related]
31. Novel, semi-automated, 60-min-assay to determine von Willebrand factor cleaving activity of ADAMTS-13.
Kostousov V; Fehr J; Bombeli T
Thromb Res; 2006; 118(6):723-31. PubMed ID: 16430944
[TBL] [Abstract][Full Text] [Related]
32. Current management of thrombotic thrombocytopenic purpura.
Kremer Hovinga JA; Meyer SC
Curr Opin Hematol; 2008 Sep; 15(5):445-50. PubMed ID: 18695366
[TBL] [Abstract][Full Text] [Related]
33. Successful management of pregnancy-associated thrombotic thrombocytopenic purpura by monitoring ADAMTS13 activity.
Yamashita E; Okada H; Yorioka H; Fujita S; Nishi K; Komiyama Y; Kanzaki H
J Obstet Gynaecol Res; 2012 Mar; 38(3):567-9. PubMed ID: 22381108
[TBL] [Abstract][Full Text] [Related]
34. [Thrombotic thrombocytopenic purpura. Reduced activity of von Willebrand factor cleaving protease].
Kunze A; Terborg C; Gerth J; Heide G; Witte OW
Nervenarzt; 2004 Aug; 75(8):785-9. PubMed ID: 15034657
[TBL] [Abstract][Full Text] [Related]
35. Thrombotic thrombocytopenic purpura--the role of ADAMTS13 assay in clinical practice.
Duraković N; Radonić R; Gasparović V
Coll Antropol; 2010 Sep; 34(3):1087-91. PubMed ID: 20977108
[TBL] [Abstract][Full Text] [Related]
36. Inherited ADAMTS13 deficiency: unique presentation and treatment.
Born H; Peters A; Ettinger R
Pediatr Blood Cancer; 2008 May; 50(5):956-7. PubMed ID: 18240172
[TBL] [Abstract][Full Text] [Related]
37. Concurrent thrombotic thrombocytopenic purpura and antiphospholipid syndrome: a rare and severe clinical combination.
Díaz-Cremades J; Fernández-Fuertes F; Ruano JA; Tapia M; Soler S; Bosch JM; Caballero M; González-San Miguel JD
Br J Haematol; 2009 Nov; 147(4):584-5. PubMed ID: 19694716
[No Abstract] [Full Text] [Related]
38. [Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].
Kato S; Fujimura Y
Rinsho Byori; 2015 Oct; 63(10):1228-36. PubMed ID: 26897861
[TBL] [Abstract][Full Text] [Related]
39. [Successful treatment with rituximab in a patient with refractory thrombotic thrombocytopenic purpura refractory to plasma exchange].
Koshino M; Kudou D; Okoshi Y; Obara N; Simizu S; Mukai HY; Suzukawa K; Hasegawa Y; Kojima H; Nagasawa T; Chiba S
Rinsho Ketsueki; 2010 Feb; 51(2):127-31. PubMed ID: 20379104
[TBL] [Abstract][Full Text] [Related]
40. The von Willebrand factor-cleaving protease (ADAMTS-13) and the diagnosis of thrombotic thrombocytopenic purpura (TTP).
Kremer Hovinga JA; Studt JD; Lämmle B
Pathophysiol Haemost Thromb; 2003 Sep-2004 Dec; 33(5-6):417-21. PubMed ID: 15692254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
